Purpose Transurethral Resection of the Bladder (TURB) is a very common endoscopic procedure. Perioperative antimicrobial prophylaxis (AMP) is used to reduce the risk of infectious complications. However, there is a lack of knowledge about both incidence of infectious complications after TURB and advantage of AMP in general. The objective of this study is to determinate the prevalence of post-operative infectious complications after routine TURB without AMP. Methods We retrospectively reviewed clinical data of all patients who underwent TURB in the same Academic Urological Department between January 2011 and December 2013. We consider as relevant for analysis, patients that underwent TURB without receiving any AMP. Infection was defined as a body temperature >37.5 °C sustained for at least 24h. Sepsis was defined according to the third international consensus definition for sepsis and septic shock. Results In the period of the study, 223 TURBs were performed without use of AMP. Mean age was 70,3 years (Standard deviation [SD] 11,3). Mean operative time was: 25.14 minutes (SD 16). Median length of hospital stay was 3 days (IQR: 2-4). 6 (2,7%) patients developed postoperative infective complications. No case of sepsis was reported. 2 (0,9%) patients received an antimicrobial therapy with fluoroquinolones despite absence of any signs of infection. 215 (96,4%) patients-TURBs did not receive any antimicrobial drugs and did not developed any infectious complications. Conclusion In our series, infectious complications after TURB occurred in less than 3% of cases. In conclusion AMP should not be routinely used prior TURB.

Perioperative antimicrobial prophylaxis for preventing infectious complications after transurethral resection of the bladder: to use or not to use?

Rizzo, Michele
;
Verzotti, Enrica;Di Cosmo, Giacomo;Pavan, Nicola;Umari, Paolo;Trombetta, Carlo;Liguori, Giovanni
2020

Abstract

Purpose Transurethral Resection of the Bladder (TURB) is a very common endoscopic procedure. Perioperative antimicrobial prophylaxis (AMP) is used to reduce the risk of infectious complications. However, there is a lack of knowledge about both incidence of infectious complications after TURB and advantage of AMP in general. The objective of this study is to determinate the prevalence of post-operative infectious complications after routine TURB without AMP. Methods We retrospectively reviewed clinical data of all patients who underwent TURB in the same Academic Urological Department between January 2011 and December 2013. We consider as relevant for analysis, patients that underwent TURB without receiving any AMP. Infection was defined as a body temperature >37.5 °C sustained for at least 24h. Sepsis was defined according to the third international consensus definition for sepsis and septic shock. Results In the period of the study, 223 TURBs were performed without use of AMP. Mean age was 70,3 years (Standard deviation [SD] 11,3). Mean operative time was: 25.14 minutes (SD 16). Median length of hospital stay was 3 days (IQR: 2-4). 6 (2,7%) patients developed postoperative infective complications. No case of sepsis was reported. 2 (0,9%) patients received an antimicrobial therapy with fluoroquinolones despite absence of any signs of infection. 215 (96,4%) patients-TURBs did not receive any antimicrobial drugs and did not developed any infectious complications. Conclusion In our series, infectious complications after TURB occurred in less than 3% of cases. In conclusion AMP should not be routinely used prior TURB.
Pubblicato
https://www.liebertpub.com/doi/abs/10.1089/end.2019.0523
File in questo prodotto:
File Dimensione Formato  
2391480-2-6.pdf

non disponibili

Tipologia: Documento in Versione Editoriale
Licenza: Copyright Editore
Dimensione 2.66 MB
Formato Adobe PDF
2.66 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
11368_2954835_print.pdf

accesso aperto

Descrizione: Post Print VQR3
Tipologia: Bozza finale post-referaggio (post-print)
Licenza: Digital Rights Management non definito
Dimensione 3.25 MB
Formato Adobe PDF
3.25 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11368/2954835
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 4
social impact